Country stories

Direct access to all the country stories presented in the progress report.

Strategic indicators and data

  • Mission indicators

    Mission indicators

    The GAVI Alliance relies on three indicators, each with specific targets, to measure progress towards fulfilling our mission.

    Under-five mortality rate in GAVI-supported countries
    (per 1,000 live births)

    Under-five mortality rate in GAVI-supported countries (per 1,000 live births)

    Source: Level and Trends in Child Mortality Report 2013: United Nations Inter-agency Group for Child Mortality Estimation

    Child mortality in GAVI-supported countries fell from 78 to 73 deaths per 1,000 live births between 2010 and 2012, with vaccines responsible for part of the drop. As a result of the unprecedented number of vaccine introductions and increasing vaccine coverage, the Alliance is on track to reduce child mortality to 68 per 1,000 live births by 2015.
     
     
     

    Number of future deaths averted (millions)

    Number of future deaths averted

    Source: GAVI and Bill & Melinda Gates Foundation Joint Impact Modelling

    Projections indicate that by the end of 2013 vaccines from the GAVI Alliance will have averted more than 2.2 million future deaths. The Alliance expects to meet its target of averting 3.9 million future deaths from 2011 to the end of 2015. In addition, 500,000 future deaths averted are projected through GAVI-funded measles vaccine campaigns between 2013 and 2015.
     
     
     

    Number of children immunised with GAVI Alliance support (millions)

    Number of children immunised with GAVI support

    Source: WHO/UNICEF Estimates of National Immunization Coverage, 2013; United Nations Population Division, Department of Economic and Social Affairs, World Population Prospects: The 2012 Revision

    In 2013, projections indicate approximately 48 million children
    were immunised with GAVI-supported vaccines. Estimates will be finalised after 2013 WHO/UNICEF immunisation coverage estimates are released in July 2014.
     
    The GAVI Alliance expects to meet its target of immunising 243 million children between 2011 and 2015 across all of its approved vaccine programmes..
     
     
     

  • Goal 1 strategic indicators

    Strategic goal 01: Accelerate the uptake and use of underused and new vaccines

    Country introductions of new and underused vaccines

    Pentavalent vaccine
    Number of countries

    Number of countries that have introduced the pentavalent vaccine

    By the end of 2013, the pentavalent vaccine had been introduced in 72 of 73 GAVI-supported countries, exceeding the 2015 target of 69.

    Pneumococcal vaccine
    Number of countries

    Number of countries that have introduced pneumococcal vaccine

    The cumulative number of pneumococcal vaccine introductions reached 38, slightly above expectations for the year.

    Rotavirus vaccine
    Number of countries

    Number of countries that have introduced the rotavirus vaccine

    Rotavirus introductions were slightly below 2013 expectations due to constraints on supplies of preferred product formulations. As the supply issue will be resolved in 2014, the number of introductions is expected to be back on track to meet 2015 targets.

    Source: GAVI Alliance, 2013

    Coverage of new and underused vaccines*

    Pentavalent vaccine, 3rd dose
    Coverage (%)

    penta3

    Pneumococcal vaccine, 3rd dose
    Coverage (%)

    pneumo3

    Rotavirus vaccine, last dose
    Coverage (%)

    rota-last

    Delays in introductions related to vaccine supply constraints and countries’ readiness meant that in 2012 the GAVI Alliance fell short of its annual coverage targets for all vaccines. The Alliance expects to gain ground against the coverage targets, especially for pneumococcal vaccine.

    Source: WHO/UNICEF Estimates of National Immunization Coverage, 2013

    * GAVI Alliance estimates depend on the availability of WHO and UNICEF data for vaccine coverage. At the time of publication, 2013 data were not available.

  • Goal 2 strategic indicators

    Strategic goal 02: Contribute to strengthening the capacity of integrated health systems to deliver immunisation


    Drop-out-rate-between-DTP1-and-DTP3

    The drop-out rate measures the percentage of children that have received the first but not the third dose of diphtheria- tetanus-pertussis (DTP)-containing vaccines. According to WHO/UNICEF estimates for 2012, the value for this indicator has remained flat at 12 percentage points, and the GAVI Alliance is not on track to meet the 2015 target of ten percentage points.

    Source: WHO/UNICEF Estimates of National Immunization Coverage, 2013

    Coverage-of-three-doses-of-diphtheria-tetanus-pertussis-containing-vaccine

    This indicator measures the strength of the routine system in reaching children with three doses of DTP-containing vaccine at the appropriate times. Average DTP3 coverage in GAVI- MCV1 coverage (%) supported countries has stagnated in recent years.
    This trend is driven by weaknesses in routine immunisation systems, particularly in large-population countries that have the greatest influence on the weighted average coverage level across the 73 GAVI-supported countries. For example, the five countries with the largest numbers of unimmunised children saw their DTP3 coverage drop by a weighted average of 3 percentage points between 2010 and 2012, while coverage in the other 68 countries increased by 3 percentage points over the same period despite population growth.

    Source: WHO/UNICEF Estimates of National Immunization Coverage, 2013

    Equity-in-immunisation

    Data for 2013 showed an increase in the percentage of countries that are closing gaps in immunisation coverage between children in the poorest – and most vulnerable – households and those in least poor households. This suggests an improvement in equity in immunisation in GAVI-supported countries, although more time and accelerated efforts are needed to determine whether the GAVI Alliance will be able to meet the 2015 target.

    Source: GAVI Alliance, 2014 (aggregated from various household survey estimates)

    First-dose-of-measles-vaccine-coverage

    The GAVI Alliance is taking measures to help raise measles vaccine coverage through its new PBF approach to HSS. The Alliance’s support to measles vaccine campaigns focuses on activities that also help strengthen routine immunisation services.

    Source: WHO/UNICEF Estimates of National Immunization Coverage, 2013

  • Goal 03 – strategic indicators

    Strategic goal 03: Increase the predictability of global financing and improve the sustainability of national financing for immunisation

    Total resources available to meet demand (US$ millions)
     

    Total-resources-available-to-meet-demand

    The GAVI Alliance has to date mobilised 100% of the resources required to finance country demand in the current strategy period.

    Source: GAVI Alliance, 2014

    Signed grant agreements versus total pledges, 2011–2015 (US$ millions)

    Signed-grant-agreements-versus-total-pledges-2011–2015

    By the end of 2013, 98% of the donor pledges made for the period 2011–2015 had been signed as formal grant agreements.

    Source: GAVI Alliance, 2014

    Country investment in vaccines per child
    Average expenditure per child (US$)

    Country-investment-in-vaccines-per-child

    Country investments in vaccines per child increased from US$ 3.80 in 2010 to US$ 4.80 in 2012. Due to an ongoing shift to a more robust method and source for tracking this indicator, for now, there is no specific target. Progress is still tracked each year against the general target of demonstrating an increasing trend.

    Source: WHO/UNICEF Joint Reporting Form and country annual progress reports 2012

    Fulfilment of co-financing commitments
    Proportion of countries (%)

    Fulfilment-of-co-financing-commitments

    The fulfilment of co-financing commitments dropped in 2013, with 14 countries in default by the end of the year. However, only four countries (6%) did not make any contribution towards their co-financing costs in 2013. The remaining 10 made partial payments. Despite the underlying trend, funds transferred by countries towards their co-financing commitments in 2013 were 10% higher than the total in 2012.

    Source: UNICEF Supply Division and the PAHO Revolving Fund, 2014

  • Goal 04 – strategic indicators

    Strategic goal 04: Shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries

    Total cost to fully immunise a child with pentavalent, pneumococcal and rotavirus vaccines
    Selected vaccine package price (US$)

    Total cost to fully immunise a child

    The total vaccine cost of fully immunising a child with pentavalent, pneumococcal and rotavirus vaccines fell from US$ 35 in 2010 to US$ 22 in 2013.

    Source: UNICEF Supply Division, 2014

    Security of supply
    (number of products offered as % of 5-year target)

     

    Security-of-supply

    By tracking the number of products offered in response to tenders for the GAVI Alliance market, the Alliance measures vaccine supply security. Since 2010, the number of products has increased from 54% to 79% of the target. While the number of products offered did not change from 2012 to 2013, the Alliance remains on track to nearly double the number of products offered in response to tenders for supply between 2010 and 2015.

    Source: UNICEF Supply Division, 2014

  • Click on an image to see a larger version within a gallery

    To save a graph to for your use, ‘right-click’ on an image and ‘save as’ to your PC.

Homepage

The GAVI Alliance 2013 Annual Progress Report

Published in June 2014